Drug Profile
INO 1401
Alternative Names: INO1401; SynCon TERT; Synthetic consensus TERT DNA vaccineLatest Information Update: 28 Jun 2019
Price :
$50
*
At a glance
- Originator Inovio Pharmaceuticals
- Class Cancer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for phase-I development in Solid-tumours(Combination therapy, Second-line therapy or greater) in USA (IM, Injection)
- 28 Jun 2019 No recent reports of development identified for phase-I development in Solid-tumours(Monotherapy, Second-line therapy or greater) in USA (IM, Injection)